DICHIARA, MARIA
 Distribuzione geografica
Continente #
AS - Asia 2.059
NA - Nord America 1.302
EU - Europa 1.150
SA - Sud America 454
AF - Africa 51
OC - Oceania 1
Totale 5.017
Nazione #
US - Stati Uniti d'America 1.240
SG - Singapore 613
CN - Cina 470
RU - Federazione Russa 466
BR - Brasile 369
IT - Italia 347
VN - Vietnam 274
HK - Hong Kong 214
KR - Corea 166
IN - India 75
FR - Francia 57
JP - Giappone 50
BD - Bangladesh 49
GB - Regno Unito 41
DE - Germania 38
NL - Olanda 35
FI - Finlandia 32
AR - Argentina 31
TW - Taiwan 31
CA - Canada 25
MX - Messico 25
IE - Irlanda 24
AT - Austria 19
ZA - Sudafrica 19
ID - Indonesia 18
IQ - Iraq 14
KE - Kenya 14
IR - Iran 12
UA - Ucraina 12
EC - Ecuador 11
ES - Italia 11
CO - Colombia 10
PL - Polonia 10
AE - Emirati Arabi Uniti 9
PH - Filippine 9
TR - Turchia 9
VE - Venezuela 8
CH - Svizzera 7
CL - Cile 7
PE - Perù 7
PK - Pakistan 7
LT - Lituania 6
PY - Paraguay 6
AL - Albania 4
AZ - Azerbaigian 4
BE - Belgio 4
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
KG - Kirghizistan 4
RS - Serbia 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
UZ - Uzbekistan 4
BY - Bielorussia 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
SE - Svezia 3
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EG - Egitto 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
Totale 5.014
Città #
Dallas 406
Singapore 352
Hefei 226
Hong Kong 168
Seoul 154
Moscow 134
Santa Clara 112
Ho Chi Minh City 100
Beijing 82
Los Angeles 78
San Jose 68
Ashburn 64
Hanoi 63
Council Bluffs 51
Milan 48
Siena 48
Lauterbourg 43
Bengaluru 41
Tokyo 41
The Dalles 37
Florence 36
Chicago 26
São Paulo 26
Rome 25
Dublin 24
Buffalo 23
Taipei 18
Helsinki 17
Redondo Beach 16
Nuremberg 15
Catania 13
Haiphong 13
Lappeenranta 13
Vienna 13
Johannesburg 12
Mexico City 12
New York 12
Orem 12
Salt Lake City 11
Tehran 11
Rio de Janeiro 10
Chennai 9
Da Nang 9
Frankfurt am Main 9
Belo Horizonte 8
Lucca 8
Turin 8
Warsaw 8
Amsterdam 7
Baghdad 7
Bologna 7
London 7
Montreal 7
Quito 7
Asunción 6
Biên Hòa 6
Curitiba 6
Denver 6
Dobong-gu 6
Lima 6
Manaus 6
Phoenix 6
Phủ Lý 6
Brooklyn 5
Cape Town 5
Dhaka 5
Hải Dương 5
Manchester 5
Nairobi 5
Piscataway 5
Poplar 5
Porto Alegre 5
Salvador 5
Santo André 5
Seattle 5
Toronto 5
Zurich 5
Abidjan 4
Atlanta 4
Baku 4
Bishkek 4
Boardman 4
Bogotá 4
Brasília 4
Brescia 4
Caivano 4
Campinas 4
Campo Grande 4
Caracas 4
Chai Wan 4
Columbus 4
Draper 4
Ha Kwai Chung 4
Hillsboro 4
Hortolândia 4
Houston 4
Islamabad 4
Kwun Tong 4
Macaé 4
Manila 4
Totale 2.991
Nome #
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients 335
Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds 328
Biostimulants for Sustainable Food Production: Effects of Wood Distillate to Fortify Chickpea Flour for Development of Functional Bakery Products 224
Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3 167
Discovery of p-Trifluoromethylbenzohydrazide Derivatives as Potent Antiviral Agents against Monkeypox Virus 148
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: design, synthesis, and pharmacological evaluation 142
Novel N-normetazocine derivatives with opioid Agonist/Sigma-1 receptor antagonist profile as potential analgesics in inflammatory pain 137
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 126
Structural and molecular insight into Piperazine and Piperidine derivatives as Histamine H3 and Sigma-1 receptor antagonists with promising antinociceptive properties 119
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity 119
Cytotoxicity profiles and neuroprotective properties of the novel ifenprodil analogues as sigma ligands 113
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 111
Unlocking the potential of biostimulants in sustainable agriculture: Effect of wood distillate on the nutritional profiling of apples 110
Tuning properties for blood-brain barrier permeation: a statistics-based analysis 108
Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors 108
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] derivatives as potent and selective sigma receptor ligands: stereochemistry and pharmacological properties 108
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 105
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 105
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors 105
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain 104
Correction to “Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents” 103
Designing drugs optimized for both blood–brain barrier permeation and intra-cerebral partition 103
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity 103
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity 102
Discovery, affinity maturation and multimerization of small molecule ligands against human tyrosinase and tyrosinase-related protein 1 101
Novel N-Substituted benzomorphan-based compounds: from MOR-agonist/DOR-antagonist to biased/unbiased MOR agonists 98
Nitric oxide photo-donor hybrids of ciprofloxacin and norfloxacin: a shift in activity from antimicrobial to anticancer agents 94
Synthesis, computational insights, and evaluation of novel sigma receptors ligands 92
New Insights into the Opioid Analgesic Profile of cis-(−)-N-Normetazocine-derived Ligands 90
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 88
Exploiting the power of stereochemistry in drug action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as potent Sigma-1 receptor antagonist 88
Structure–Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis 83
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors 82
Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational Approaches 82
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: preliminary studies as a potential multifunctional agent against uveal melanoma 81
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 79
Sigma-2 receptor ligands QSAR model dataset 77
Sigma receptor ligands carrying a nitric oxide donor nitrate moiety: synthesis, In silico, and biological evaluation 75
H2S releasing molecules in pharmaceutical development 74
Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5ʹ-monophosphate glycosidase 73
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 68
Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents 67
Open Source Antibiotics: Simple Diarylimidazoles Are Potent against Methicillin-Resistant Staphylococcus aureus 66
Repurposing of human kinase inhibitors in neglected protozoan diseases 64
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 57
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors 57
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 52
Novel Sigma Receptors Ligands-Nitric Oxide Photodonor: Molecular Hybrids for Double-Targeted Antiproliferative Effect 46
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 39
Totale 5.206
Categoria #
all - tutte 14.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202363 0 0 0 0 0 0 0 0 0 0 62 1
2023/2024159 1 0 0 5 0 3 18 2 5 0 18 107
2024/20251.403 39 27 130 45 138 120 39 61 191 79 95 439
2025/20263.581 255 511 510 582 506 96 454 129 130 234 111 63
Totale 5.206